Evaluation of Heterosubtypic Immune Responses in Older People Before and After Seasonal and Pandemic Influenza Vaccination

Trial Profile

Evaluation of Heterosubtypic Immune Responses in Older People Before and After Seasonal and Pandemic Influenza Vaccination

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Jul 2015

At a glance

  • Drugs Influenza A virus vaccine-H5N1 (Primary) ; Influenza virus vaccine; MF 59
  • Indications Influenza A virus H5N1 subtype; Influenza virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 02 Jun 2014 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 07 Aug 2012 Planned End Date changed from 1 Aug 2010 to 1 Dec 2012 as reported by ClinicalTrials.gov.
    • 28 Oct 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top